FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38617911000001102: Darolutamide 300mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1380651000001110 Darolutamide 300mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1380661000001113 Darolutamide 300mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Darolutamide 300mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has specific active ingredient Darolutamide false Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Is a Darolutamide false Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Has specific active ingredient Darolutamide true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Is a Darolutamide true Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nubeqa 300mg tablets (Bayer Plc) Is a True Darolutamide 300mg tablets Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets 112 tablet Has VMP True Darolutamide 300mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start